Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 22, 2021, titled "Submission of first biosimilar filing with EMA".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 22, 2021, titled "Submission of first biosimilar filing with EMA".